Exhibit 3.1
AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES
OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF
VANDA PHARMACEUTICALS INC.
Pursuant to Section 151 of the
General Corporation Law of the State of Delaware
Vanda Pharmaceuticals Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Section 103 thereof, certifies:
That pursuant to the authority vested in the Board of Directors of the Corporation (the “Board”) in accordance with the provisions of the Certificate of Incorporation of the Corporation (as heretofore amended and restated, the “Certificate of Incorporation”), the Board on September 25, 2008, adopted a resolution authorizing the creation of a series of 30,000 shares of Preferred Stock designated as “Series A Junior Participating Preferred Stock” and the Certificate of Designation for the Series A Junior Participating Preferred Stock was filed with the Secretary of State of Delaware on the same date (the “Series A Certificate”);
That no shares of Series A Junior Participating Preferred Stock have been issued; and
That pursuant to the authority conferred upon the Board by the Certificate of Incorporation, on April 17, 2024, the Board adopted the following resolution for purposes of amending and restating the Series A Certificate:
RESOLVED, that pursuant to the authority vested in the Board of this Corporation in accordance with the provisions of the Certificate of Incorporation, the Certificate of Designation, filed with the Secretary of State of Delaware on September 25, 2008, which created a series of Preferred Stock, par value $0.001 per share, of the Corporation designated as “Series A Junior Participating Preferred Stock” (such Certificate of Designation, the “Series A Certificate”), be and hereby is amended and restated in its entirety as set forth herein, and the terms of the Series A Junior Participating Preferred Stock be and hereby are amended and restated in their entirety such that the number of shares, and the voting and other powers, preferences and relative, participating, optional or other rights of the Series A Junior Participating Preferred Stock and the qualifications, limitations and restrictions thereof are as follows:
Section 1. Designation and Amount. The shares of such series will be designated as “Series A Junior Participating Preferred Stock.” The Series A Junior Participating Preferred Stock will have a par value of $0.001 per share, and the number of shares constituting such series will be 150,000. Such number of shares may be increased or decreased by resolution of the Board, except that no decrease will reduce the number of shares of Series A Junior Participating Preferred Stock to a number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of outstanding options, rights or warrants or upon the exercise of any options, rights or warrants issuable upon conversion of any outstanding securities issued by the Corporation convertible into Series A Junior Participating Preferred Stock.
1